Read my earlier posts Twinturbo. VLA need US$300k per month just to keep the lights on and VLA have no cash. This leaves them with around $7mill of option/convertible note funding over the next 2 years to fund an FDA approved phase II. There is no way they will be able to conduct a decent sized phase II trial with $7mill. $25mill is more in the ball park, which leaves them with a $15-20mill shortfall. VLA management would have to have rocks in their head not to take advantage of this price spike and conduct a raising or at least put in place another dilution financing instrument.
$55mill is a huge EV for a phase I biotech without sufficient funding in place, and VLA management would know this.
Day traders might push this thing higher in the short term, but just remember, a sensible short term valuation for VLA, all things considered, is around 5-7c.
And if The Speculator is true to form, he will lock in profits tomorrow.
- Forums
- ASX - By Stock
- 50mill market cap
Read my earlier posts Twinturbo. VLA need US$300k per month just...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online